Interviews

DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.

Goodbody Health Phytovista Laboratories extends its ISO 17025 UKAS accreditation (Interview)

Goodbody Health Group (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: SCNNF) subsidiary Phytovista Laboratories Chief Scientific Officer Nick Clarkson joins DirectorsTalk Interviews to discuss an extension to..

itim Group improving the financial performances of store-based retailers (Interview)

itim Group plc (LON:ITIM) Founder and CEO Ali Athar joins DirectorsTalk Interviews to tell us more about the company. Ali explains what the company does, who its typical customers are,..

Xpediator stock value looks very attractive (Analyst Interview)

Xpediator Plc (LON:XPD) is the topic of conversation when Robin Byde, Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Robin reminds us what the company does, what the company announced..

Cadence Minerals excited as first phase of Amapa Iron Ore Project completes (Interview)

Cadence Minerals plc (LON:KNDC) CEO Kiran Morzaria joins DirectorsTalk Interviews to discuss its acquisition of 20% of the Amapa Iron Ore Project. Kiran explains what the acquisition entailed, its estimated..

Strix Group deliver a good performance and now look undervalued (Analyst Interview)

Strix Group plc (LON:KETL) is the topic of conversation when Andy Hanson Research Director at Zeus Capital joins DirectorsTalk Interviews. Andy shares his thoughts on the company performance from the..

Cizzle Biotechnology to take early lung cancer test to £3b China market (Interview)

Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms joins DirectorsTalk Interviews to discuss a full commercial development and royalty agreement to develop and market Cizzle Biotechnologies early lung cancer..

Open Orphan world’s first COVID-19 characterisation study (Interview)

Open Orphan plc (LON:ORPH) Executive Chairman Cathal Friel joins DirectorsTalk Interviews to discuss results from the world’s first COVID-19 characterisation study. Cathal explains what these results mean for Open Orphan,..

Tirupati Graphite ramping up to become major graphite producer (Interview)

Tirupati Graphite PLC (LON:TGR) Executive Chairman & Managing Director Shishir Poddar joins DirectorsTalk Interviews to keep us up to date with progress being made at its Graphite Mines. Shishir shares..

Quadrise Fuels bioMSAR™ Aquafuels testing results endorsement of potential (Interview)

Quadrise Fuels International plc (LON:QFI) CEO Jason Miles joins DirectorsTalk Interviews to discuss the results of the latest bioM-SAR™ testing at Aquafuel Research and also the appointment of Andy Morrison..

Fintel digitisation of SaaS & subscription business improves earnings quality (Analyst Interview)

Fintel plc (LON:FNTL) is the topic of conversation when Robin Savage, Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Robin talks us through the key points in the company pre-close..

Staffline Group positive momentum to continue into FY22 (Analyst Interview)

Staffline Group plc (LON:STAF) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk Interviews. Mike explains who Staffline Group are, what makes them..

LSL Property Services has considerable value and strategically positioned (Analyst Interview)

LSL Property Services plc (LON:LSL) is the topic of conversation when Robin Savage, Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Robin talks us through the key points in the..

Safestyle UK should outperform peers in the sector (Analyst Interview)

Safestyle UK plc (LON:SFE) is the topic of conversation when Andy Hanson, Research Director at Zeus Capital joins DirectorsTalk Interviews. Andy explains how Safestyle UK traded during the year, the..

Goodbody Health a pivotal moment in community pharmacy (Interview)

Goodbody Health Inc. (CSE:GDBY / AQSE:GDBY / FRA: 484 / OTC: SCNNF) Scientific Advisory Committee Member and Chair of the Pharmacy Focus Group Ian Strachan joins DirectorsTalk Interviews to tell..

N4 Pharma encouraging data, oncology the quickest route to clinic (Interview)

N4 Pharma plc (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss encouraging data from its oncology research. Nigel describes the behavior of Nuvec, explains why now a focus on oncology,..

Lookers cheap shares and exciting new strategy (Analyst Interview)

Lookers plc (LON:LOOK) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk Interviews. Mike talks us through the key points from the company’s..

AMTE Power expected to be key beneficiary of ATF in Gigafactory plans (Analyst Interview)

AMTE Power plc (LON:AMTE) is the topic of conversation when WH Ireland Senior Analyst Matthew Davis joins DirectorsTalk Interviews. Matthew explains why its been a busy week for the battery..

Epwin Group “valuation is really appealing” (Analyst Interview)

Epwin Group plc (LON:EPWN) is the topic of conversation when Research Director at Zeus Capital, Andy Hanson joins DirectorsTalk Interviews. With Epwin Group having announced its year-end trading update in..

Ilika in a strong cash position to go through to commercialisation (Analyst Interview)

Ilika plc (LON:IKA) is the topic of conversation when partner and clean-tech equities specialist at Baden Hill, Dr Tom McColm joins DirectoirsTalk Interviews. With Ilika providing a half-year report for..

Anexo Group deliver strong revenues with significant opportunities ahead (Interview)

Anexo Group plc (LON:ANX) Head of Investor Relations Nick Dashwood Brown joins DirectorsTalk Interviews to discuss a trading Update for the year ended 31st December 2021. Nick explains why fleet..

Search

Funds

Interviews

Search

Funds

Interviews

FTSE 100

Funds